The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab plus short-course chemo-radiotherapy for conversion therapy of unresectable ESCC (LATE): A proof-of-concept, phase Ib trial.
 
Ning Jiang
No Relationships to Disclose
 
Ming Jiang
No Relationships to Disclose
 
Xiangzhi Zhu
No Relationships to Disclose
 
Feng Jiang
No Relationships to Disclose
 
Wei Ren
No Relationships to Disclose
 
Guochun Cao
No Relationships to Disclose
 
Cheng Chen
No Relationships to Disclose
 
Jingfeng Mei
No Relationships to Disclose
 
Yixin Li
No Relationships to Disclose
 
Qishu Tan
No Relationships to Disclose
 
Yidan Hong
No Relationships to Disclose
 
Zhen Guo
No Relationships to Disclose
 
Jingyuan Zhang
No Relationships to Disclose
 
Xiaochen Huang
No Relationships to Disclose
 
Yang Zhao
No Relationships to Disclose